,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'destiny-breast04']
standing ovation for destiny-breast04 data release, practice-changing option for women with "her2low" breast cancer #asco22 #tdxd #enhertu -- honored to be part of daiichi sankyo bringing this treatment option forward for patients! 
this is my personal Twitter, no affiliation with my professional work or clients